Document is current
Any future updates will be listed below
-
Authors
Ingels, Alexandre https://orcid.org/0000-0002-0043-6520
Campi, Riccardo https://orcid.org/0000-0001-5237-0888
Capitanio, Umberto https://orcid.org/0000-0001-9225-1795
Amparore, Daniele
Bertolo, Riccardo https://orcid.org/0000-0003-0260-4601
Carbonara, Umberto
Erdem, Selcuk https://orcid.org/0000-0002-3514-1394
Kara, Önder https://orcid.org/0000-0003-1197-2932
Klatte, Tobias https://orcid.org/0000-0002-4392-6861
Kriegmair, Maximilian C.
Marchioni, Michele https://orcid.org/0000-0002-1702-4127
Mir, Maria C.
Ouzaïd, Idir
Pavan, Nicola https://orcid.org/0000-0001-7355-7625
Pecoraro, Angela
Roussel, Eduard
de la Taille, Alexandre
- License Information
-
More Information
Article History
Accepted: 29 March 2022
First Online: 11 May 2022
Competing interests
: A.I. declares competing interests with Intuitive Surgical, Ipsen, Bristol-Myers Squibb, Pfizer and Elypta. D.A. declares competing interests with Elypta. R.C. declares competing interests with Elypta, Janssen and Merck. E.R. declares competing interests with Pfizer and Ipsen. The other authors declare no competing interests.
